Shenzhen Weiguang Biological Products Co Ltd (002880) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.022x

Based on the latest financial reports, Shenzhen Weiguang Biological Products Co Ltd (002880) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥51.60 Million ≈ $7.55 Million USD) by net assets (CN¥2.36 Billion ≈ $344.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shenzhen Weiguang Biological Products Co net asset quality index to measure how much of total assets are equity-financed.

Shenzhen Weiguang Biological Products Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Shenzhen Weiguang Biological Products Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Shenzhen Weiguang Biological Products Co's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Shenzhen Weiguang Biological Products Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Weiguang Biological Products Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Yuanli Chemical Group Co Ltd SHG:603217	-0.001x
Beijing SPC Environment Protection Tech Co Ltd SHE:002573	0.049x
Reitir fasteignafélag hf IC:REITIR	0.028x
President Bakery Public Company Limited BK:PB	0.029x
Mingchen Health Co Ltd Class A SHE:002919	0.050x
Sichuan Huiyu Pharmaceutical Co Ltd SHG:688553	0.016x
Hunan Yussen Energy Technology SHE:002986	-0.020x
Shanghai Weihong Electronic Technology Co Ltd SHE:300508	0.033x

Annual Cash Flow Conversion Efficiency for Shenzhen Weiguang Biological Products Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Shenzhen Weiguang Biological Products Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 002880 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.45 Billion ≈ $357.80 Million	CN¥263.18 Million ≈ $38.51 Million	0.108x	+35.89%
2024-12-31	CN¥2.24 Billion ≈ $328.40 Million	CN¥177.77 Million ≈ $26.01 Million	0.079x	-59.28%
2023-12-31	CN¥2.05 Billion ≈ $299.34 Million	CN¥397.94 Million ≈ $58.23 Million	0.195x	+30198.49%
2022-12-31	CN¥1.87 Billion ≈ $273.28 Million	CN¥1.20 Million ≈ $175.46K	0.001x	-99.53%
2021-12-31	CN¥1.79 Billion ≈ $261.68 Million	CN¥246.89 Million ≈ $36.13 Million	0.138x	-26.25%
2020-12-31	CN¥1.62 Billion ≈ $237.61 Million	CN¥303.96 Million ≈ $44.48 Million	0.187x	+46.04%
2019-12-31	CN¥1.45 Billion ≈ $212.00 Million	CN¥185.70 Million ≈ $27.17 Million	0.128x	+68.15%
2018-12-31	CN¥1.31 Billion ≈ $191.08 Million	CN¥99.54 Million ≈ $14.57 Million	0.076x	+220.52%
2017-12-31	CN¥1.20 Billion ≈ $176.06 Million	CN¥28.61 Million ≈ $4.19 Million	0.024x	-90.47%
2016-12-31	CN¥506.44 Million ≈ $74.11 Million	CN¥126.41 Million ≈ $18.50 Million	0.250x	-34.53%
2015-12-31	CN¥393.71 Million ≈ $57.61 Million	CN¥150.09 Million ≈ $21.96 Million	0.381x	-12.24%
2014-12-31	CN¥308.86 Million ≈ $45.20 Million	CN¥134.17 Million ≈ $19.63 Million	0.434x	+364.69%
2013-12-31	CN¥223.88 Million ≈ $32.76 Million	CN¥20.93 Million ≈ $3.06 Million	0.093x	-89.11%
2012-12-31	CN¥135.00 Million ≈ $19.76 Million	CN¥115.88 Million ≈ $16.96 Million	0.858x	--

About Shenzhen Weiguang Biological Products Co Ltd

SHE:002880 China Biotechnology

Market Cap

$672.72 Million

CN¥4.60 Billion CNY

Market Cap Rank

#10671 Global

#2866 in China

Share Price

CN¥20.27

Change (1 day)

+0.45%

52-Week Range

CN¥18.80 - CN¥31.04

All Time High

CN¥963796.17